Value
9.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Analyst target | 9.0 |
- ▸Attractively valued
ACHV · Why this verdict
Why Achieve Life Sciences (ACHV) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The setup passed both the momentum gate at 6.7 and the asymmetry gate at a reward-to-risk ratio of 5.84, with a golden cross and price above all major moving averages framed explicitly as a breakout pattern. Chart pattern detection | Price should continue trending above its moving averages and the reward-to-risk ratio should stay well above the 1.5 bar over the next 12 months if the breakout holds. | →Stable |
| CounterQuality remains a core concern, with a score of 2.0 sitting well below the 4.0 floor, which caps position sizing at avoid regardless of the technical setup. | ||
The quality score of 2.0 remains below the 4.0 floor cited as grounds to exit, driven by a weak Piotroski F-score of 2 out of 9, no competitive moat, and cash-burning free cash flow. Quality breakdown | The Piotroski F-score should climb out of the bottom quartile and free cash flow should move toward breakeven over the next 12 months for the exit signal to reverse. | →Stable |
| CounterThe current ratio component reads a strong 8.9, indicating substantial near-term liquidity to fund continued operations despite the cash burn. | ||
The analyst-target upside is enormous at 87.7%, backed by a value score of 9.0 and sentiment notes describing the name as attractively valued, though coverage is explicitly described as light. Sentiment breakdown | Analyst coverage should broaden and the price target should be reaffirmed by additional analysts over the next 12 months for the upside case to be considered reliable. | →Stable |
| CounterLight analyst coverage explicitly dampens the reliability of the signal, so a target built on thin coverage may not hold up as more analysts weigh in. | ||
The options market shows an extreme put/call ratio of 13.00 alongside implied volatility of 99%, with price trading above the $5 max-pain level, all flagged explicitly in the risk notes. Risk breakdown | The put/call ratio should normalize back toward parity and implied volatility should ease over the next 12 months if the extreme hedging positioning unwinds. | →Stable |
| CounterMomentum and technical notes show volume accumulating and price above the 200-day moving average, a bullish combination that is difficult to reconcile with such heavy put positioning. | ||
Over the trailing four quarters the company posted two misses, one in-line result, and one beat, most recently beating by 36.36%, leaving the average surprise positive at 5.7%. Earnings | Beats should outnumber misses over the next four quarters and the average surprise should continue rising for the earnings trend to be considered improving. | →Stable |
| CounterTwo of the last four quarters were outright misses, so a positive average driven mostly by one large beat may not persist. | ||
The setup passed both the momentum gate at 6.7 and the asymmetry gate at a reward-to-risk ratio of 5.84, with a golden cross and price above all major moving averages framed explicitly as a breakout pattern.
→StableChart pattern detection
- Expectation
- Price should continue trending above its moving averages and the reward-to-risk ratio should stay well above the 1.5 bar over the next 12 months if the breakout holds.
CounterQuality remains a core concern, with a score of 2.0 sitting well below the 4.0 floor, which caps position sizing at avoid regardless of the technical setup.
The quality score of 2.0 remains below the 4.0 floor cited as grounds to exit, driven by a weak Piotroski F-score of 2 out of 9, no competitive moat, and cash-burning free cash flow.
→StableQuality breakdown
- Expectation
- The Piotroski F-score should climb out of the bottom quartile and free cash flow should move toward breakeven over the next 12 months for the exit signal to reverse.
CounterThe current ratio component reads a strong 8.9, indicating substantial near-term liquidity to fund continued operations despite the cash burn.
The analyst-target upside is enormous at 87.7%, backed by a value score of 9.0 and sentiment notes describing the name as attractively valued, though coverage is explicitly described as light.
→StableSentiment breakdown
- Expectation
- Analyst coverage should broaden and the price target should be reaffirmed by additional analysts over the next 12 months for the upside case to be considered reliable.
CounterLight analyst coverage explicitly dampens the reliability of the signal, so a target built on thin coverage may not hold up as more analysts weigh in.
The options market shows an extreme put/call ratio of 13.00 alongside implied volatility of 99%, with price trading above the $5 max-pain level, all flagged explicitly in the risk notes.
→StableRisk breakdown
- Expectation
- The put/call ratio should normalize back toward parity and implied volatility should ease over the next 12 months if the extreme hedging positioning unwinds.
CounterMomentum and technical notes show volume accumulating and price above the 200-day moving average, a bullish combination that is difficult to reconcile with such heavy put positioning.
Over the trailing four quarters the company posted two misses, one in-line result, and one beat, most recently beating by 36.36%, leaving the average surprise positive at 5.7%.
→StableEarnings
- Expectation
- Beats should outnumber misses over the next four quarters and the average surprise should continue rising for the earnings trend to be considered improving.
CounterTwo of the last four quarters were outright misses, so a positive average driven mostly by one large beat may not persist.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Achieve Life Sciences shows a genuine technical breakout with an outsized reward-to-risk setup and a large analyst-target upside, but weak underlying quality and extreme options hedging keep the position capped at avoid.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
2.0/10data confidence 100%| Component | Sub-score |
|---|---|
| Gross margin | 0.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 8.9 |
| FCF quality | 0.0 |
| Moat | 3.2 |
| Piotroski F | 2.2 |
- ▸Cash-burning (FCF negative)
- ▸No competitive moat
- ▸Weak Piotroski F-Score: 2/9
- ▸Quality concerns
Growth
5.0/10data confidence 50%Momentum
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.0 |
| MACD | 7.7 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 2.3 |
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
8.1/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 8.2 |
| Price target | 10.0 |
| erm sentiment | 5.6 |
- ▸Light analyst coverage (10.0) — signal dampened
- ▸Analyst upside: 122%
Insider
7.5/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
- ▸Institutions accumulating
Peer rank
2.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 5.0 |
| quality rank | 0.0 |
| growth rank | 5.0 |
Technical
5.1/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 3.0 |
| support resistance | 3.9 |
| 52w position | 7.5 |
| gap | 6.0 |
Risk (lower is worse)
3.8/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 6.0 |
| days to cover | 4.6 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 2.6 |
| debt equity | 4.2 |
- ▸High IV: 123%
- ▸Above max pain $2
Catalyst
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 1.1 |
| earnings timing | 5.0 |
| surprise avg | 5.4 |
- ▸Earnings concerns: 1B/2M
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (8)
- MOMENTUM:6.8>=5.5
- ASYMMETRY:6.2>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:29d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (0)
none
Reward-to-Risk
6.22
Upside
+93.3%
Downside
15.0%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 61, MACD bullish
EdgeInst Constrain — Small cap ($0.7B) below institutional reach
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Value at 9.0 could not lift the engine output above the verdict floor.
The strongest dimensions are Value at 9.0, Sentiment at 8.1, and Insider at 7.5; the weakest are Quality at 2.0, Peer rank at 2.7, and Risk (lower is worse) at 3.8. The V9 engine cleared all gates, producing an asymmetric reward-to-risk of 6.22 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Breakout With High Asymmetry
Trip ifRSI falls below 50 from the current reading near 66, reversing the bullish breakout signal.
- P2Quality Below Floor Exit Signal
Trip ifQuality score rises above 4.0 from the current 2.0.
- P3Steep Analyst Upside Light Coverage
Trip ifUpside to analyst target compresses below 20% from the current 87.7%.
- P4Elevated Put Call Hedging
Trip ifPut/call ratio falls below 3.0 from the current 13.00.
- P5Mixed Earnings Track Record
Trip ifEarnings surprise falls below 0% (a miss) in the next reported quarter.